Physician

Miguel Angel Garcia-Caro, M.D.

According to 2025 Medicare claims, Miguel Garcia-Caro, M.D. (NPI: 1508859455) practices rheumatology in the Alexandria, LA market, with the plurality of this provider's patient population coming from Rapides, LA. This provider's primary affiliated billing organization is MIGUEL A GARCIA-CARO MD LLC (NPI: 1326424029; TIN: 465233000) and primary practice location at 71303-3621. Garcia-Caro is affiliated with the Aledade 155 National MSSP (ACO ID: A5358), participating under the MSSP model.

Garcia-Caro's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 392 traditional Medicare patients, billed 97,829 HCPCS/CPT codes, and received $1,449,737 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 10,626 prescription claims across 575 beneficiaries totaling $7,017,264 in drug costs, led by Acthar (Corticotropin). 2021 DME data shows 54 claims. Open Payments data shows 75 records totaling $1,477. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a higher plateau to a lower plateau, from $3,297,428 to $1,449,737. In contrast, Part D prescription costs have moved sharply higher in recent years, from $2,521,224 to $7,017,264. For DME billing, this smaller-volume category moved up and down with repeated peaks and valleys, starting at $8,083 and ending at $23,362.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	720	177,963	$3,297,428
2016	672	185,602	$3,314,348
2017	653	191,505	$3,506,774
2018	598	170,056	$3,230,197
2019	534	152,786	$3,055,845
2020	436	123,324	$2,329,736
2021	415	113,552	$1,971,663
2022	407	119,747	$1,624,339
2023	400	116,679	$1,702,332
2024	392	97,829	$1,449,737

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	574	13,195	$2,521,224
2016	606	12,944	$2,329,531
2017	595	12,405	$3,115,881
2018	569	11,039	$3,563,200
2019	526	9,816	$3,095,292
2020	498	9,888	$3,164,878
2021	481	9,171	$3,691,675
2022	500	9,553	$4,773,951
2023	510	10,473	$5,958,954
2024	575	10,626	$7,017,264

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	14	$1,871
2016	N/R	89	$6,341
2017	N/R	50	$3,487
2018	N/R	57	$4,544
2019	N/R	57	$2,847
2020	N/R	71	$1,924
2021	N/R	54	$1,194
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	88	138	$97
96413	Administration of chemotherapy into vein, 1 hour or less	86	630	$93
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	375	1,396	$63
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	128	171	$13
J3301	Injection, triamcinolone acetonide, not otherwise specified, 10 mg	75	372	$1

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Acthar	Corticotropin	16	515	$1,357,235
Humira(Cf) Pen	Adalimumab	89	2,496	$724,231
Orencia	Abatacept/Maltose	146	4,088	$653,049
Enbrel Sureclick	Etanercept	47	1,316	$368,925
Benlysta	Belimumab	60	1,680	$257,927

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	75	$1,477	Amgen Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Miguel Angel Garcia-Caro, M.D.?

Tedicare shows public-source Medicare data for Miguel Angel Garcia-Caro, M.D. (NPI 1508859455), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Miguel Angel Garcia-Caro, M.D. have ACO affiliation data?

Miguel Angel Garcia-Caro, M.D. is shown with ACO affiliation data for Aledade 155 National MSSP (MSSP, ACO ID A5358).

What billing organization is linked to Miguel Angel Garcia-Caro, M.D.?

Miguel Angel Garcia-Caro, M.D. is linked to MIGUEL A GARCIA-CARO MD LLC (billing NPI 1326424029) in the available physician profile data.

Does Miguel Angel Garcia-Caro, M.D. have Open Payments data?

Miguel Angel Garcia-Caro, M.D. has 75 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.